Zobrazeno 1 - 10
of 43
pro vyhledávání: '"M. Alaguero"'
Autor:
E. García Carús, L. Caminal Montero, J. Fernández Suárez, C. Salmerón Menéndez, M. Alaguero, J. Fernández Domínguez, L. Villa Bajo, A. Rodríguez Esteban, L. García, A. Rodríguez-Guardado
Publikováno v:
Cirugía Cardiovascular, Vol 30, Iss 1, Pp 54- (2023)
Externí odkaz:
https://doaj.org/article/19eda82215ce47c2b741abe8824fd2f3
Autor:
M.ª E. Gómez Álvarez, M. Alaguero Calero, C. Durán Román, A. Olabarri Blanco, L. García Riaño, G. Solís Sánchez, C. Bousoño García
Publikováno v:
Nutrición Hospitalaria, Vol 20, Iss 4, Pp 242-248 (2005)
La nutrición parenteral domiciliaria es una terapia necesaria pero infrautilizada en España, respecto de los países de nuestro entorno. El primer foro de discusión de la SENPE ha estudiado este problema y aconseja entre otras iniciativas el dise
Externí odkaz:
https://doaj.org/article/8fc3fb82a74f4e28a3c03739223381d8
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
I De La Fuente Villaverde, S Fernández Lastras, C Álvarez Asteinza, I Maray Mateos, CL Fernández Laguna, L Macía Rivas, M Eiroa Osoro, L Oyague López, M Alaguero Calero, A Lozano Blázquez
Publikováno v:
Section 6: Education and research.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bf20c9098580fd5bf883f1042a9ca531
https://doi.org/10.1136/ejhpharm-2022-eahp.368
https://doi.org/10.1136/ejhpharm-2022-eahp.368
Autor:
A Lozano-Blázquez, B Zarate Tamames, M Alaguero Calero, Á Pieras López, R Menárguez Blanc, A Arias, C Carriles Fernandez
Publikováno v:
Section 5: Patient Safety and Quality Assurance.
Background Pharmaceutical validation consists in verifying medical prescriptions (dosage, route of administration, pharmaceutical presentation) and checking the suitability of treatment in the approval indications, patient characteristics and domicil
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aa0cac70d05399a29bbcecb4feb3a971
https://doi.org/10.1136/ejhpharm-2019-eahpconf.547
https://doi.org/10.1136/ejhpharm-2019-eahpconf.547
Autor:
M Alaguero Calero, A Lozano-Blázquez, A Rodriguez Palomo, N Martínez Lago, FJ Alvarez Manceñido, Alicia Arias, M. Sánchez Cánovas, Gema Aguado, C Hernández Pérez, A Martinez Torron
Publikováno v:
Section 4: Clinical Pharmacy Services.
Background To date, there has been no phase III trial to establish the optimal duration of first-line chemotherapy for patients with advanced gastric cancer (AGC): limited treatment, maintenance of some drugs or treatment until progression. Purpose A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::856620342dcefe3d827bdf7459b461ab
https://doi.org/10.1136/ejhpharm-2019-eahpconf.255
https://doi.org/10.1136/ejhpharm-2019-eahpconf.255
4CPS-123 Role of docetaxel in combination with cisplatin and capecitabine in advanced gastric cancer
Autor:
E Martínez de Castro Medical, M Mangas, I Zapico García, A Martinez Torron, Aitor Azkarate, F Alvarez-Manceñido, A Rodriguez Palomo, A Lozano-Blázquez, Alberto Carmona-Bayonas, M Alaguero Calero
Publikováno v:
Eur J Hosp Pharm
Background Advanced gastric cancer (AGC) does not have a chemotherapy regimen accepted as standard. Docetaxel has demonstrated benefits associated with cisplatin and 5-fluorouracil in a phase III trial but with modest results and high toxicity, and w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::25278fc393a634d474bb2efa9da841c2
https://doi.org/10.1136/ejhpharm-2018-eahpconf.214
https://doi.org/10.1136/ejhpharm-2018-eahpconf.214
Autor:
A Martinez Torron, I Zapico García, F Alvarez-Manceñido, M Alaguero Calero, P. Reguera, A Lozano-Blázquez, G Aguado, Aniel Sanchez, Alberto Carmona-Bayonas, A Rodriguez Palomo
Publikováno v:
Eur J Hosp Pharm
Background The Phase III TOGA study confirmed an increased survival for patients with HER2-positive advanced gastric cancer (AGC) treated with trastuzumab in combination with cisplatin and fluoropyrimidine (CF). However, there is little information o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::928c50725778c8f760e13f2e21322ccc
https://doi.org/10.1136/ejhpharm-2018-eahpconf.213
https://doi.org/10.1136/ejhpharm-2018-eahpconf.213
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
María E, Gómez Alvarez, M, Alaguero Calero, C, Durán Román, A, Olabarri Blanco, L, García Riaño, G, Solís Sánchez, C, Bousoño García
Publikováno v:
Nutricion hospitalaria. 20(4)
Home parenteral nutrition (HPN) is a necessary but under-used therapy in Spain as compared to other European countries. This problem has been studied at the 1st Discussion Forum of the Spanish Society for Parenteral and Enteral Nutrition. One of its
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b5775b584a18e09ff6b545a349c81878
https://pubmed.ncbi.nlm.nih.gov/16562823
https://pubmed.ncbi.nlm.nih.gov/16562823